Quinolones are among the most commonly utilized antimicrobials for treatment of infections caused by P. aeruginosa. Plasmid mediated quinolone resistance (PMQR) is an expanding clinical concern worldwide with fluctuating prevalence rates. Spread of PMQR determinants along with other resistance mechanisms to P. aeruginosa clinical isolates would constrain the adequacy of quinolones in treatment of Pseudomonas infections. | Plasmid mediated quinolone resistance determinants among nosocomial clinical pseudomonas aeruginosa Isolates
